BIOMAT Database Logo BIOMAT Database Logo

New drugs and a pharmaceutical industry. 1968

O Fitzgerald

UI MeSH Term Description Entries
D004345 Drug Industry That segment of commercial enterprise devoted to the design, development, and manufacture of chemical products for use in the diagnosis and treatment of disease, disability, or other dysfunction, or to improve function. Industries, Pharmaceutic,Industry, Drug,Industry, Pharmaceutic,Industry, Pharmaceutical,Pharmaceutical Industry,Drug Industries,Industries, Drug,Industries, Pharmaceutical,Pharmaceutic Industries,Pharmaceutic Industry,Pharmaceutical Industries
D004358 Drug Therapy The use of DRUGS to treat a DISEASE or its symptoms. One example is the use of ANTINEOPLASTIC AGENTS to treat CANCER. Chemotherapy,Pharmacotherapy,Therapy, Drug,Chemotherapies,Drug Therapies,Pharmacotherapies,Therapies, Drug
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

O Fitzgerald
Biotechnology and the pharmaceutical industry. New cardiovascular drugs.
November 1986, Hypertension (Dallas, Tex. : 1979),
O Fitzgerald
Pharmaceutical industry screening for new antiepileptic drugs.
January 1998, Advances in neurology,
O Fitzgerald
Fewer new drugs from the pharmaceutical industry.
February 2003, BMJ (Clinical research ed.),
O Fitzgerald
Orphan drugs--a pharmaceutical industry viewpoint.
January 1983, Progress in clinical and biological research,
O Fitzgerald
Developing and testing of new drugs by the pharmaceutical industry.
January 1960, Clinical pharmacology and therapeutics,
O Fitzgerald
The challenge of new drugs to the pharmaceutical industry.
January 1959, Antibiotics annual,
O Fitzgerald
New Jersey's pharmaceutical industry.
January 1985, The Journal of the Medical Society of New Jersey,
O Fitzgerald
New Jersey's pharmaceutical industry.
January 2003, New Jersey medicine : the journal of the Medical Society of New Jersey,
O Fitzgerald
[PHARMACEUTICAL INDUSTRY AND PERSONALIZED MEDICINE: A PARADIGM SHIFT IN THE DEVELOPMENT OF NEW DRUGS].
January 2015, Revue medicale de Liege,
O Fitzgerald
Economic evaluation of drugs: a UK pharmaceutical industry perspective.
January 1992, PharmacoEconomics,
Copied contents to your clipboard!